Outside of some notable struggles among small and unproven companies, this
has been a surprisingly strong year for life sciences companies. This
strength, and relatively health multiples, is coming despite relatively
unimpressive revenue growth and signs that 2013 could be a very tough
year for the academic and government lab sectors. Consequently, while Life Technologies (Nasdaq:LIFE) is certainly worth a spot on a watch list, it's hard to muster a lot of enthusiasm for the stock right now.
To read more, please click on the link below:
http://www.investopedia.com/
No comments:
Post a Comment